Pyrls

Emerging

Modern mobile drug reference app for prescribers with dosing, interactions, and patient education; 50K+ healthcare providers from YC-backed competing with Epocrates for clinical decision support.

Company Overview

About Pyrls

Pyrls is a Minneapolis-based healthcare technology company providing a modern medical drug reference app that enables clinicians, pharmacists, and healthcare trainees to prescribe medications, check interactions, and educate patients more effectively — delivering clinical decision support at the point of care through a mobile-first reference tool that competes with Epocrates as the go-to medication reference for healthcare providers. Founded in 2020 and backed by Y Combinator, Pyrls serves 50,000+ healthcare providers and trainees across hundreds of organizations, achieving $500,000 in revenue in 2024 with a 34-person team.

Business Model & Competitive Advantage

Pyrls' drug reference platform provides the clinical data clinicians need for safe prescribing: dosing guidelines by indication, route, and patient population (pediatric, renal impairment, hepatic impairment); drug interaction checker; contraindications; pregnancy and lactation safety classifications; and patient education materials for medication counseling. The platform is designed for medical residents, pharmacists, nurse practitioners, and physician assistants who need quick access to accurate drug information during clinical workflows.

Competitive Landscape 2025–2026

In 2025, Pyrls competes in the clinical decision support and drug reference app market with Epocrates (athenahealth-owned, the dominant drug reference app for physicians), Medscape Reference (WebMD), Lexicomp (Wolters Kluwer), and Micromedex for clinical drug reference at point of care. Epocrates has long dominated this category through its free-to-use model funded by pharmaceutical advertising (drug promotions to prescribers) — a model that has faced scrutiny from medical ethics perspectives. Pyrls' competitive differentiation includes a modern interface (Epocrates' UI has been criticized as dated), pharmacist-specific features, and a clean direct subscription model without pharmaceutical advertising. The 2025 strategy focuses on growing through medical school and residency program institutional contracts, expanding the clinical content beyond drug reference into broader clinical decision support, and building integrations with EHR systems for seamless reference during documentation.

Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Pyrls is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Not So Random Others

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Hermes Robotics

Manufacturing
B2bHardwareManufacturingAi PoweredAutomationStartup

Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma

Duckie

Infrastructure
B2bPlatformAi PoweredAutomation

Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit

Zeffy

Nonprofit Tech
B2bSaas

Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs

Oda Studio

Real Estate & Property Tech
B2bProptechAi PoweredSaas

Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal

Compare Pyrls with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Pyrls

Claim This Profile

Are you from Pyrls? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Pyrls Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Pyrls vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →